Related Experiment Video
Updated: Jul 5, 2026

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
Published on: March 17, 2023
[Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera]
Meltem Tekin1, Serkan Gökaslan, Erdem Diker
1Ankara Numune Eğitim ve Araştirma Hastanesi Kardiyoloji Kliniği, Ankara. meltemtekin@gmail.com
Insights
Myeloproliferative neoplasms like polycythemia vera and essential thrombocythemia can cause heart attacks due to blood clots. Early treatment with medications and hydroxyurea can lead to recovery.
Area of Science:
- Cardiology
- Hematology
Background:
- Myeloproliferative neoplasms (MPNs) are associated with an increased risk of thrombosis.
- Coronary thrombosis is a significant cause of myocardial infarction (MI) in MPN patients, often linked to hyperviscosity and thrombocytosis.
Observation:
- This study presents three cases of acute myocardial infarction in young male patients with MPNs.
- One patient had polycythemia vera, and two had essential thrombocythemia.
- None of the patients had traditional cardiovascular risk factors like diabetes, hypertension, or hyperlipidemia.
Findings:
- All patients received comprehensive medical treatment for acute coronary syndrome, including aspirin, beta-blockers, statins, and anticoagulation.
- One patient received early thrombolytic therapy.
- Hydroxyurea was administered for essential thrombocythemia.
- Follow-up angiographies confirmed patent coronary arteries in all cases, indicating successful management.
Implications:
- This case series highlights the importance of considering MPNs in the differential diagnosis of myocardial infarction, especially in younger individuals without risk factors.
- Effective management of both acute coronary syndrome and the underlying myeloproliferative neoplasm is crucial for favorable outcomes.
- Further research is needed to establish optimal management strategies for coronary thrombosis in MPN patients.
Abstract:
Little is known about the management of coronary thrombosis in myeloproliferative disease. The occurrence of myocardial infarction in myeloproliferative disease is mostly attributed to coronary thrombosis due to hyperviscosity and thrombocytosis. We presented three cases of acute myocardial infarction associated with polycythemia vera in one patient (male, age 33 years) and essential thrombocytosis in two patients (male, ages 36 and 46 years). None of the patients had diabetes mellitus, hypertension, hyperlipidemia, or a positive family history. One patient with early presentation received thrombolytic therapy, and all the patients were treated with aspirin, beta-blocker, angiotensin 2 receptor blocker, statin, low-molecular-weight heparin, parenteral nitrate, and clopidogrel for acute coronary syndrome, and hydroxyurea for essential thrombocytosis. Control angiographies showed patent coronary arteries in all the cases.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
08:51Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
Published on: September 20, 2024
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Venous Thrombosis I: Introduction